Johnson & Johnson (NYSE:JNJ) is at all-time highs, once again. And given the strong year-to-date performance, I want to examine this consumer behemoth more closely to try and determine the pros and cons of investing in JNJ.
Although I'm familiar with the company at a high level, I'm curious to dig deeper into the financial trends that have driven its strong price performance. The 7,723% return since 1978 (before dividends) is downright amazing. But is it worth paying 18 times cash flow?
And what exactly is driving this long-term growth? It's a good question. In short, JNJ has three segments that sell to consumers all over the world. The segments are: Consumer, pharmaceutical and medical device.
